October 30, 2026 · PDUFA decision
INO PDUFA decision: a negative outcome, -7.8%
On October 30, 2026, INO-3107 — Inovio Pharmaceuticals, Inc. (Respiratory Papillomatosis) reached its PDUFA decision. The result was a negative outcome, and the stock moved -7.8% in the window around the event. It had already run -27.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$0.77
1d before
$0.71
Event day
$0.71
1d after
$0.71
5d after
Our prediction vs. the result
CatalystAlert called this one up (+12.0% expected); the stock actually moved -7.8%. Model confidence at the time: 60%.
See the full scored track recordPre-catalyst setup
-27.0%
30-day run-up
11075%
30-day volatility
2.4×
volume spike